These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 38532370

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Risk of prostate cancer for men with prior negative biopsies undergoing magnetic resonance imaging compared with biopsy-naive men: A prospective evaluation of the PLUM cohort.
    Patel HD, Koehne EL, Shea SM, Bhanji Y, Gerena M, Gorbonos A, Quek ML, Flanigan RC, Goldberg A, Gupta GN.
    Cancer; 2022 Jan 01; 128(1):75-84. PubMed ID: 34427930
    [Abstract] [Full Text] [Related]

  • 26. Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study.
    van der Leest M, Cornel E, Israël B, Hendriks R, Padhani AR, Hoogenboom M, Zamecnik P, Bakker D, Setiasti AY, Veltman J, van den Hout H, van der Lelij H, van Oort I, Klaver S, Debruyne F, Sedelaar M, Hannink G, Rovers M, Hulsbergen-van de Kaa C, Barentsz JO.
    Eur Urol; 2019 Apr 01; 75(4):570-578. PubMed ID: 30477981
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Combining clinical parameters and multiparametric magnetic resonance imaging to stratify biopsy-naïve men for an optimum diagnostic strategy with prostate-specific antigen 4 ng ml-1 to 10 ng ml-1.
    Zhang CC, Tu X, Lin TH, Cai DM, Yang L, Qiu S, Liu ZH, Yang L, Wei Q.
    Asian J Androl; 2023 Apr 01; 25(4):492-498. PubMed ID: 36571328
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Values of multiparametric and biparametric MRI in diagnosing clinically significant prostate cancer: a multivariate analysis.
    Feng X, Chen X, Peng P, Zhou H, Hong Y, Zhu C, Lu L, Xie S, Zhang S, Long L.
    BMC Urol; 2024 Feb 16; 24(1):40. PubMed ID: 38365673
    [Abstract] [Full Text] [Related]

  • 35. A clinical available decision support scheme for optimizing prostate biopsy based on mpMRI.
    Hou Y, Jiang KW, Zhang J, Bao ML, Shi HB, Qu JR, Cheng G, Zhang YD.
    Prostate Cancer Prostatic Dis; 2022 Apr 16; 25(4):727-734. PubMed ID: 35067674
    [Abstract] [Full Text] [Related]

  • 36. Reducing prostate biopsies and magnetic resonance imaging with prostate cancer risk stratification.
    Davik P, Remmers S, Elschot M, Roobol MJ, Bathen TF, Bertilsson H.
    BJUI Compass; 2022 Sep 16; 3(5):344-353. PubMed ID: 35950035
    [Abstract] [Full Text] [Related]

  • 37. Avoiding Unnecessary Magnetic Resonance Imaging (MRI) and Biopsies: Negative and Positive Predictive Value of MRI According to Prostate-specific Antigen Density, 4Kscore and Risk Calculators.
    Falagario UG, Martini A, Wajswol E, Treacy PJ, Ratnani P, Jambor I, Anastos H, Lewis S, Haines K, Cormio L, Carrieri G, Rastinehad AR, Wiklund P, Tewari A.
    Eur Urol Oncol; 2020 Oct 16; 3(5):700-704. PubMed ID: 31548130
    [Abstract] [Full Text] [Related]

  • 38. Clinically Significant Prostate Cancer Detection After a Negative Prebiopsy MRI Examination: Comparison of Biparametric Versus Multiparametric MRI.
    Gan JM, Kikano EG, Smith DA, Rao S, Podury R, Wang M, Durieux JC, Paspulati RM, Ponsky L, Ramaiya NH, Tirumani SH.
    AJR Am J Roentgenol; 2022 May 16; 218(5):859-866. PubMed ID: 34817189
    [Abstract] [Full Text] [Related]

  • 39. Do all patients with suspicious prostate cancer need Multiparametric Magnetic Resonance Imaging before prostate biopsy?
    Teixeira Anacleto S, Neves Alberto J, Carvalho Dias E, Sousa Passos P, Cerqueira Alves M.
    Arch Ital Urol Androl; 2022 Mar 28; 94(1):32-36. PubMed ID: 35352522
    [Abstract] [Full Text] [Related]

  • 40. Reproducibility and Accuracy of the PRIMARY Score on PSMA PET and of PI-RADS on Multiparametric MRI for Prostate Cancer Diagnosis Within a Real-World Database.
    Emmett L, Papa N, Counter W, Calais J, Barbato F, Burger I, Eiber M, Roberts MJ, Agrawal S, Franklin A, Xue A, Rasiah K, John N, Moon D, Frydenberg M, Yaxley J, Stricker P, Wong K, Coughlin G, Gianduzzo T, Kua B, Ho B, Nguyen A, Liu V, Lee J, Hsiao E, Sutherland T, Perry E, Fendler WP, Hope TA.
    J Nucl Med; 2024 Jan 02; 65(1):94-99. PubMed ID: 38050155
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.